Kim et al. demonstrated that CD133 -a putative marker of melanoma-initiating cells [151, 152]- acts in concert with the chemokine receptor CXCR4 to facilitate a metastatic phenotype [151]. The gene discussed is PROM1; the disease is melanoma.